These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10859783)

  • 1. Percentiles of the product of uncertainty factors for establishing probabilistic reference doses.
    Gaylor DW; Kodell RL
    Risk Anal; 2000 Apr; 20(2):245-50. PubMed ID: 10859783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical warfare agents: estimating oral reference doses.
    Opresko DM; Young RA; Faust RA; Talmage SS; Watson AP; Ross RH; Davidson KA; King J
    Rev Environ Contam Toxicol; 1998; 156():1-183. PubMed ID: 9597943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical review and probabilistic health hazard assessment of cleaning product ingredients in all-purpose cleaners, dish care products, and laundry care products.
    Wang Z; Dinh D; Scott WC; Williams ES; Ciarlo M; DeLeo P; Brooks BW
    Environ Int; 2019 Apr; 125():399-417. PubMed ID: 30743146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining uncertainty factors in deriving human exposure levels of noncarcinogenic toxicants.
    Kodell RL; Gaylor DW
    Ann N Y Acad Sci; 1999; 895():188-95. PubMed ID: 10676417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: general framework.
    Slob W; Pieters MN
    Risk Anal; 1998 Dec; 18(6):787-98. PubMed ID: 9972582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data.
    Pieters MN; Kramer HJ; Slob W
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):108-11. PubMed ID: 9671565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
    Pohl HR; Chou CH; Ruiz P; Holler JS
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the LOAEL-to-NOAEL uncertainty factor for mild adverse effects from acute inhalation exposures.
    Alexeeff GV; Broadwin R; Liaw J; Dawson SV
    Regul Toxicol Pharmacol; 2002 Aug; 36(1):96-105. PubMed ID: 12383722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel uncertainty factors and thresholds of toxicological concern for health hazard and risk assessment: Application to cleaning product ingredients.
    Wang Z; Scott WC; Williams ES; Ciarlo M; DeLeo PC; Brooks BW
    Environ Int; 2018 Apr; 113():357-376. PubMed ID: 29452931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiencing a probabilistic approach to clarify and disclose uncertainties when setting occupational exposure limits.
    Vernez D; Fraize-Frontier S; Vincent R; Binet S; Rousselle C
    Int J Occup Med Environ Health; 2018 Jul; 31(4):475-489. PubMed ID: 29546881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors.
    Gaylor DW; Kodell RL; Chen JJ; Krewski D
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):151-7. PubMed ID: 10341145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation.
    Bokkers BG; Slob W
    Toxicol Sci; 2005 Jun; 85(2):1033-40. PubMed ID: 15772368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A straw man proposal for a quantitative definition of the RfD.
    Hattis D; Baird S; Goble R
    Drug Chem Toxicol; 2002 Nov; 25(4):403-36. PubMed ID: 12378950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating noncancer uncertainty factors: are ratios NOAELs informative?
    Brand KP; Rhomberg L; Evans JS
    Risk Anal; 1999 Apr; 19(2):295-308. PubMed ID: 10765406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signal-to-noise crossover dose as the point of departure for health risk assessment.
    Sand S; Portier CJ; Krewski D
    Environ Health Perspect; 2011 Dec; 119(12):1766-74. PubMed ID: 21813365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative influences of dermal and inhalational routes of exposure on hazards of cleaning product ingredients among mammalian model organisms.
    Wang Z; Wang YYL; Scott WC; Williams ES; Ciarlo M; DeLeo P; Brooks BW
    Environ Int; 2021 Dec; 157():106777. PubMed ID: 34314977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.